SPOTLIGHT -
Dallas-Essilor Laboratories of America will add about $7 million in annual sales to its totals with the purchase of the assets of three laboratories in Phoenix, Tucson, and Denver.
Study: Children with vision impairment have reduced quality of life
ROP: Treating and preventing blindness in preterm babies
WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression
Managing a changing landscape of IRD pediatric cases
VUMC participates in national study to test eye drops for myopia
Prevent Blindness declares August as children’s eye health and safety month